JAK2 and acquired polycythemia vera: Patients acquiring TET2 mutations presented with a more severe phenotype resembling PV if the clone already harbored the JAK2V617F mutation (the ‘JAK2-first’), whereas patients with ‘TET2-first’ clones appeared to have a less aggressive ET-like phenotype.